.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Predicting mortality risk is vital for managing patients with end-stage renal disease. Monitoring outcomes through tools like the N-SII in hemodialysis survival is becoming essential for personalized care. Recent research introduced a composite scoring system called the nutritional-systemic immune inflammation (N-SII) score. This metric combines the Geriatric Nutritional Risk Index (GNRI) and the systemic immune inflammation index (SII). Consequently, it offers clinicians a more robust way to evaluate long-term prognosis.
Researchers conducted a comprehensive review of 2,859 patients on maintenance hemodialysis. They aimed to identify indicators with superior prognostic accuracy. The study found that the N-SII composite score yielded an area under curve (AUC) of 0.850. This performance significantly outperformed the isolated use of GNRI or SII alone. Specifically, GNRI and SII achieved AUCs of 0.761 and 0.782, respectively. Moreover, the N-SII score proved effective in predicting mortality from various causes, including cardiovascular and cerebrovascular events.
The results emphasize the synergy between nutritional status and systemic inflammation. Malnutrition often exacerbates inflammatory responses, which then accelerates vascular damage. By integrating these two factors, the N-SII score provides a comprehensive risk profile. Therefore, healthcare providers can better stratify patients and prioritize those requiring aggressive nutritional support. Additionally, this score serves as a simple yet powerful tool for routine clinical practice.
The N-SII score is a composite index. It incorporates the Geriatric Nutritional Risk Index (GNRI), which measures nutritional status, and the systemic immune inflammation index (SII), which reflects inflammatory levels.
It integrates both nutrition and inflammation, which are two major factors driving mortality in dialysis patients. By combining them, it achieves higher accuracy than using either marker individually.
This score allows for better risk stratification. Consequently, doctors can identify high-risk patients more effectively and implement targeted interventions to improve long-term outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replacement for professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The N-SII composite score, merging GNRI and SII, significantly enhances the prediction of long-term survival for patients on maintenance hemodialysis....
4 months ago
A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Left ventricular thrombus is a severe complication of acute decompensated heart failure. This clinical review explores the pathophysiology, imaging challenges, and pharmacotherapeutic considerations of laminated thrombi, evaluating the evolving role of direct oral anticoagulants versus traditional warfarin.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
